AI-Based Hamstring Injury Risk Analysis and Effects of the FUNBALL Program

by palligoelme@gmail.com | Jun 16, 2026 | Clinical Trials

​ Conditions: Healthy; Healthy Adult Male Interventions: Other: FUNBALL Prevention Program Sponsors: Yeditepe University Completed Conditions: Healthy; Healthy Adult Male Interventions: Other: FUNBALL Prevention Program Sponsors: Yeditepe University...

Botulinum Toxin Type A Injection Sites for Oral Commissure Ptosis

by palligoelme@gmail.com | Jun 15, 2026 | Clinical Trials

​ Conditions: Facial Aging; Melomental Folds; Oral Commissure Ptosis Interventions: Drug: OnabotulinumtoxinA (Upper Depressor Anguli Oris Injection); Drug: OnabotulinumtoxinA (Lower Depressor Anguli Oris Injection) Sponsors: Peking University Not yet...

To Evaluate the Safety and Tolerability of Anti-Human CD70 T-Cell Injection in Subjects With Advanced/Metastatic Renal Cancer

by palligoelme@gmail.com | Jun 15, 2026 | Clinical Trials

​ Conditions: Renal Cell Carcinoma (RCC) Interventions: Drug: Anti-Human CD70 T-Cell Injection Sponsors: Hrain Biotechnology Co., Ltd.; RenJi Hospital Not yet recruiting Conditions: Renal Cell Carcinoma (RCC) Interventions: Drug: Anti-Human CD70 T-Cell Injection...

Multivitamin and Mineral Supplementation and Healthy Aging

by palligoelme@gmail.com | Jun 15, 2026 | Clinical Trials

​ Conditions: Healthy Aging; Multivitamin and Mineral Supplementation Interventions: Dietary Supplement: MVM Core Blend; Dietary Supplement: MVM Gold Blend; Dietary Supplement: Placebo Sponsors: University of California, San Diego; HALEON Recruiting Conditions:...

Postoperative Analgesia Using a Perineural Catheter Versus a Single Nerve Block in Rearfoot Surgery

by palligoelme@gmail.com | Jun 15, 2026 | Clinical Trials

​ Conditions: Hindfoot Surgery; Analgesia; Perineural Catheter Interventions: Other: Phone contact; Device: perineural catheter; Procedure: Regional Anesthesia Sponsors: University Hospital, Angers Not yet recruiting Conditions: Hindfoot Surgery; Analgesia; Perineural...

A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

by palligoelme@gmail.com | Jun 15, 2026 | Clinical Trials

​ Conditions: ER-Positive HER2-Negative Breast Cancer Interventions: Drug: Camizestrant; Drug: Ribociclib Sponsors: AstraZeneca; ICON plc Not yet recruiting Conditions: ER-Positive HER2-Negative Breast Cancer Interventions: Drug: Camizestrant; Drug: Ribociclib...